Illumina earnings were $825.0M for the trailing 12 months ending Jun 28, 2026, with -31.8% growth year over year. The latest ILMN earnings report on Jun 28, 2026 announced Q2 2026 earnings of $207.0M, up 54.5% from last quarter. For the last reported fiscal year 2025 ending Dec 28, 2025, ILMN reported annual earnings of $850.0M, with -169.5% growth.
ILMN past earnings growth
How has ILMN's earnings growth performed historically?
On ILMN's earnings call on Jul 30, 2026, Illumina (NASDAQ: ILMN) reported Q2 2026 earnings per share (EPS) of $1.37, up 8.05% year over year. Total ILMN earnings for the quarter were $207.00 million. In the same quarter last year, Illumina's earnings per share (EPS) was $1.49.
As of the last Illumina earnings report, Illumina is currently profitable. Illumina's net profit (also called net income) for the twelve months ending Jun 28, 2026 was $825.00 million, a 34.42% decrease year over year.
What was ILMN's earnings growth in the past year?
As of Illumina's earnings date in Jul 30, 2026, Illumina's earnings has grown -31.82% year over year. This is 45.57 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 13.75%. ILMN earnings in the past year totalled $825.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.